TrialBlood2018

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.

Michael Dickinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.